Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about JAK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
JAK is a concept in neurodegeneration research. Key relationships include: activates, therapeutic target, inhibits. Associated with ALS, Aging, Als. Connected to 853 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | JAK |
| Key Genes/Proteins | ABCB1, ABCG2, ABL1, ACHE, AD, AD RISK GENES |
| Related Diseases | Addiction, aging, Aging |
| Related Pathways | Adaptive Immunity, Akt |
| Linked Hypotheses | 4 hypotheses |
Knowledge base pages for this entity
graph TD
JAK["JAK"]
JAK -->|"activates"| STAT3["STAT3"]
JAK -->|"regulates"| GENE_EXPRESSION["GENE_EXPRESSION"]
JAK -->|"causes"| Alzheimer_s_disease["Alzheimer's disease"]
JAK -->|"target for"| Cardiovascular["Cardiovascular"]
JAK -->|"target for"| Inflammation["Inflammation"]
JAK -->|"target for"| Als["Als"]
JAK -->|"target for"| Cancer["Cancer"]
JAK -->|"target for"| Ms["Ms"]
IL6["IL6"] -->|"activates"| JAK
SOCS["SOCS"] -->|"inhibits"| JAK
STAT3 -->|"activates"| JAK
CD4["CD4"] -->|"target for"| JAK
BCL2["BCL2"] -->|"target for"| JAK
VIRAL_INFECTIONS["VIRAL INFECTIONS"] -->|"activates"| JAK
STAT2["STAT2"] -->|"inhibits"| JAK
MTOR["MTOR"] -->|"target for"| JAK| Target | Relation | Type | Str |
|---|---|---|---|
| Nf-Κb | activates | pathway | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| Tumor | therapeutic_target | disease | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| h-cb2065e26c | targeted_by | hypothesis | 1.00 |
| Jak-Stat | activates | pathway | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| Als | inhibits | disease | 1.00 |
| Jak-Stat | inhibits | pathway | 1.00 |
| Mapk | activates | pathway | 1.00 |
| Tumor | activates | disease | 0.95 |
| Autoimmune | therapeutic_target | disease | 0.95 |
| Tumor | inhibits | disease | 0.95 |
| Cancer | associated_with | disease | 0.95 |
| Ph-Like ALL | involved_in | disease | 0.95 |
| Cancer | regulates | disease | 0.95 |
| STAT | activates | protein | 0.95 |
| Gene Expression | regulates | process | 0.95 |
| Als | treats | disease | 0.95 |
| Als | regulates | disease | 0.95 |
| neural stem cells | activates | cell_type | 0.90 |
| Chromatin | modulates | mechanism | 0.90 |
| inborn errors of immunity | associated_with | disease | 0.90 |
| JAK-STAT signaling | participates_in | pathway | 0.90 |
| NF-kB signaling | participates_in | pathway | 0.90 |
| Epigenome | modulates | mechanism | 0.90 |
| STAT3 | phosphorylates | protein | 0.90 |
| STAT3 | activates | protein | 0.90 |
| STAT3 | associated_with | gene | 0.90 |
| Metastasis | therapeutic_target | pathway | 0.90 |
| Differentiation | therapeutic_target | pathway | 0.90 |
| Apoptosis | regulates | pathway | 0.90 |
| Differentiation | regulates | pathway | 0.90 |
| Tumor | regulates | disease | 0.85 |
| Alzheimer | therapeutic_target | disease | 0.85 |
| Neuroinflammation | activates | disease | 0.85 |
| Inflammation | causes | disease | 0.85 |
| Neuroinflammation | therapeutic_target | disease | 0.85 |
| Cardiovascular | therapeutic_target | disease | 0.85 |
| Neurodegeneration | activates | disease | 0.85 |
| Malignant Cell Proliferation | associated_with | phenotype | 0.85 |
| Malignant Cell Survival | associated_with | phenotype | 0.85 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.80 |
| TGF-beta signaling | participates_in | pathway | 0.80 |
| microglia | expressed_in | cell_type | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-cb2065e26c | targets | hypothesis | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| IL-6 | therapeutic_target | gene | 1.00 |
| STAT3 | therapeutic_target | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| CYTOKINES | inhibits | gene | 1.00 |
| ERK | activates | gene | 1.00 |
| IL-6 | activates | gene | 1.00 |
| CANCER | therapeutic_target | gene | 1.00 |
| NF-KB | associated_with | gene | 0.98 |
| RAS | activates | gene | 0.90 |
| CYTOKINES | therapeutic_target | gene | 0.90 |
| NF-ΚB | activates | gene | 0.90 |
| INFLAMMATION | regulates | gene | 0.90 |
| CANCER | activates | gene | 0.90 |
| CANCER | regulates | gene | 0.90 |
| INFLAMMATION | inhibits | gene | 0.90 |
| IL6 | activates | protein | 0.87 |
| IL-6 | associated_with | gene | 0.82 |
| SOCS | inhibits | protein | 0.80 |
| Polyphenols | inhibits | compound | 0.80 |
| OXIDATIVE STRESS | activates | gene | 0.80 |
| CYTOKINES | activates | gene | 0.80 |
| TNF | inhibits | gene | 0.80 |
| IL-6 | inhibits | gene | 0.80 |
| TNF-Α | inhibits | gene | 0.80 |
| AMPK | activates | gene | 0.80 |
| AKT | regulates | gene | 0.80 |
| INFLAMMATION | causes | gene | 0.80 |
| AKT | associated_with | gene | 0.80 |
| GENES | activates | gene | 0.80 |
| CANCER | associated_with | gene | 0.80 |
| TNF-Α | activates | gene | 0.80 |
| PI3K | associated_with | gene | 0.80 |
| GENES | inhibits | gene | 0.80 |
| CANCER | inhibits | disease | 0.80 |
| STAT3 | activates | protein | 0.74 |
| AMYLOID | associated_with | protein | 0.74 |
| TNF | associated_with | gene | 0.74 |
| ASTROCYTE | enhances | cell_type | 0.70 |
| APOE | regulates | gene | 0.70 |
| CSF1R | activates | gene | 0.70 |
| ACHE | markers | gene | 0.70 |
| ACHE | inhibits | gene | 0.70 |
| DOPAMINERGIC | inhibits | cell_type | 0.70 |
| DOPAMINERGIC | activates | cell_type | 0.70 |
| AMPK | interacts_with | gene | 0.70 |
| ASTROCYTE | expressed_in | cell_type | 0.70 |
| NRF2 | inhibits | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| H2: SASP Neutralization via JAK/STAT Inhibition Preserves As | 0.550 | neurodegeneration | Do APOE4-driven senescent astrocytes cau |
| CNTF-JAK/STAT3 Reprogramming of Trained Microglia to Neuropr | 0.522 | neuroinflammation | What specific astrocyte-derived factors |
| α4β1 Integrin (VLA-4) and JAK/STAT Pathway | 0.450 | neuroinflammation | What molecular mechanisms mediate SPP1-i |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning JAK in their description or question text
No additional research found